ID

32639

Descripción

A Phase III Study to Investigate the Impact of Diamyd in Patients Newly Diagnosed With Type 1 Diabetes (EU); ODM derived from: https://clinicaltrials.gov/show/NCT00723411

Link

https://clinicaltrials.gov/show/NCT00723411

Palabras clave

Versiones (2)
  1. 9/11/18 9/11/18 -
  2. 9/11/18 9/11/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

9 de noviembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Type 1 Diabetes Mellitus NCT00723411

Inglés

Eligibility Type 1 Diabetes Mellitus NCT00723411

1 formularios  
Criteria
Descripción

Criteria

male and female patients between 10 and 20 years of age
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
insulin dependent type 1 diabetes mellitus diagnosed within the previous 3 months at time of screening
Descripción

Insulin-Dependent Diabetes Mellitus Disease length

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0011854
UMLS CUI [1,2]
C0872146
fasting c-peptide level at time of screening above 0.1 nmol/l
Descripción

Fasting C-peptide level

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2208720
elevated gad65 antibodies (gada) at time of screening
Descripción

Serum Gad65 Auto Antibodies Test Elevated

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1255118
UMLS CUI [1,2]
C3163633
main exclusion criteria:
Descripción

Exclusion Criteria Main

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
treatment with immunosuppressants or any anti-diabetic medications other than insulin
Descripción

Immunosuppressive Agents | Antidiabetics | Exception Insulin

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021081
UMLS CUI [2]
C0935929
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0021641
a history of certain diseases or conditions (e.g. anemia, hiv, hepatitis, epilepsy, head trauma, neurological diseases or cerebrovascular accident, alcohol or drug abuse etc)
Descripción

Anemia | HIV Infection | Hepatitis | Epilepsy | Craniocerebral Trauma | Nervous system disorder | Cerebrovascular accident | Substance Use Disorders

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0002871
UMLS CUI [2]
C0019693
UMLS CUI [3]
C0019158
UMLS CUI [4]
C0014544
UMLS CUI [5]
C0018674
UMLS CUI [6]
C0027765
UMLS CUI [7]
C0038454
UMLS CUI [8]
C0038586
treatment with any vaccine within 1 month prior to planned first diamyd dose or planned treatment with vaccine up to 2 months after the last injection with diamyd, excluding the influenza vaccine
Descripción

Vaccination | Exception Influenza vaccine

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0042196
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0021403
participation in other clinical trials with a new chemical entity within the previous 3 months
Descripción

Study Subject Participation Status | Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568
UMLS CUI [2]
C0013230
pregnancy or planned pregnancy within 1 year after the last diamyd dose
Descripción

Pregnancy | Pregnancy, Planned

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0032992
presence of associated serious disease or condition which in the opinion of the investigator makes the patient non-eligible for the study
Descripción

Disease Serious Study Subject Participation Status Ineligible | Condition Serious Study Subject Participation Status Ineligible

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0205404
UMLS CUI [1,3]
C2348568
UMLS CUI [1,4]
C1512714
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C0205404
UMLS CUI [2,3]
C2348568
UMLS CUI [2,4]
C1512714
Volver a la parte superior de la página

Similar models

Eligibility Type 1 Diabetes Mellitus NCT00723411

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Age
Item
male and female patients between 10 and 20 years of age
boolean
C0001779 (UMLS CUI [1])
Insulin-Dependent Diabetes Mellitus Disease length
Item
insulin dependent type 1 diabetes mellitus diagnosed within the previous 3 months at time of screening
boolean
C0011854 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Fasting C-peptide level
Item
fasting c-peptide level at time of screening above 0.1 nmol/l
boolean
C2208720 (UMLS CUI [1])
Serum Gad65 Auto Antibodies Test Elevated
Item
elevated gad65 antibodies (gada) at time of screening
boolean
C1255118 (UMLS CUI [1,1])
C3163633 (UMLS CUI [1,2])
Exclusion Criteria Main
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Immunosuppressive Agents | Antidiabetics | Exception Insulin
Item
treatment with immunosuppressants or any anti-diabetic medications other than insulin
boolean
C0021081 (UMLS CUI [1])
C0935929 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0021641 (UMLS CUI [3,2])
Anemia | HIV Infection | Hepatitis | Epilepsy | Craniocerebral Trauma | Nervous system disorder | Cerebrovascular accident | Substance Use Disorders
Item
a history of certain diseases or conditions (e.g. anemia, hiv, hepatitis, epilepsy, head trauma, neurological diseases or cerebrovascular accident, alcohol or drug abuse etc)
boolean
C0002871 (UMLS CUI [1])
C0019693 (UMLS CUI [2])
C0019158 (UMLS CUI [3])
C0014544 (UMLS CUI [4])
C0018674 (UMLS CUI [5])
C0027765 (UMLS CUI [6])
C0038454 (UMLS CUI [7])
C0038586 (UMLS CUI [8])
Vaccination | Exception Influenza vaccine
Item
treatment with any vaccine within 1 month prior to planned first diamyd dose or planned treatment with vaccine up to 2 months after the last injection with diamyd, excluding the influenza vaccine
boolean
C0042196 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0021403 (UMLS CUI [2,2])
Study Subject Participation Status | Investigational New Drugs
Item
participation in other clinical trials with a new chemical entity within the previous 3 months
boolean
C2348568 (UMLS CUI [1])
C0013230 (UMLS CUI [2])
Pregnancy | Pregnancy, Planned
Item
pregnancy or planned pregnancy within 1 year after the last diamyd dose
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Disease Serious Study Subject Participation Status Ineligible | Condition Serious Study Subject Participation Status Ineligible
Item
presence of associated serious disease or condition which in the opinion of the investigator makes the patient non-eligible for the study
boolean
C0012634 (UMLS CUI [1,1])
C0205404 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C1512714 (UMLS CUI [1,4])
C0348080 (UMLS CUI [2,1])
C0205404 (UMLS CUI [2,2])
C2348568 (UMLS CUI [2,3])
C1512714 (UMLS CUI [2,4])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial